| To Evaluate the Influence of (LUA Probiotics) on Uric Acid (NCT06969469) | Grape King Bio Ltd. | 2022-07-18 |
| Effect of Aquatic Exercise and Traditional Physical Therapy on Gout in Hypertensive Menopausal Women With Hyperuricemia (NCT05454423) | Merit University | 2022-07-01 |
| Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With Gout (NCT07752810) | Hangzhou Grand Biologic Pharmaceutical, Inc. | 2022-06-23 |
| Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation (NCT04844814) | Assistance Publique - Hôpitaux de Paris | 2022-06-02 |
| A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With Gout (NCT05256810) | Alnylam Pharmaceuticals | 2022-02-25 |
| Delivery of Enhance Fitness Trial (NCT05275348) | University of Washington | 2022-02-02 |
| Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets (NCT05168683) | Allena Pharmaceuticals | 2022-01-11 |
| A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout (NCT05007392) | Eisai Co., Ltd. | 2021-12-21 |
| Treat-to-target by Email During Urate-lowering Therapy in Gout (NCT04733079) | Assistance Publique - Hôpitaux de Paris | 2021-12-15 |
| Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients (NCT05119686) | Arthrosi Therapeutics | 2021-11-16 |
| Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects (NCT04966325) | LG Chem | 2021-09-23 |
| Medication Adherence Patterns in Rheumatic Diseases: A Behavioral Trial (NCT04776161) | Brigham and Women's Hospital | 2021-08-02 |
| Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults (NCT04886050) | LG Chem | 2021-07-31 |
| An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) (NCT04987242) | Allena Pharmaceuticals | 2021-07-16 |
| Acute Effects of Tart Cherry on Uric Acid and Biomarkers of CVD Risk in Healthy Individuals (NCT04960527) | Sheffield Hallam University | 2021-07-10 |
| Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout (NCT04953533) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-07-06 |
| A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout (NCT04956432) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-15 |
| Gout in the ED and Improving Research Participation (NCT04075903) | University of Alabama at Birmingham | 2021-06-01 |
| Tahiti-families: Polynesian Families of Gout Patients (NCT04900090) | Lille Catholic University | 2021-05-25 |
| Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old (NCT04897113) | National Medical Research Center for Rehabilitation and Balneology | 2021-05-12 |
| Epidemiology of Gout in French Polynesia (NCT04812886) | Lille Catholic University | 2021-04-29 |
| Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) (NCT04829435) | Allena Pharmaceuticals | 2021-04-21 |
| Treatment of Refractory Gout With ACTH or Methylprednisolone (NCT04808856) | Shanghai 10th People's Hospital | 2021-04-01 |
| Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C) (NCT04938024) | University of Minnesota | 2021-03-28 |
| CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies (NCT04695028) | Lille Catholic University | 2021-03-16 |
| COVID-19 Vaccination in Rheumatic Disease Patients (NCT04839315) | Mayo Clinic | 2021-02-15 |
| Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol (NCT04746989) | Brigham and Women's Hospital | 2021-02-01 |
| Post-Authorisation Safety Study of Lesinurad (NCT04072471) | AstraZeneca | 2021-01-29 |
| Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout (NCT04697602) | National Taiwan University Hospital | 2021-01-20 |
| A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia (NCT04638543) | Atom Therapeutics Co., Ltd | 2020-11-27 |
| Urica Cor Intervention (URICORI) Trial (NCT04459936) | Torkell Ellingsen | 2020-11-24 |
| Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk (NCT05309057) | University of Toronto | 2020-11-01 |
| The Influence of Urate-lowering Therapy on Sperm Quality of Male Gouty Patients：A Prospective Cohort Study (NCT04213534) | Peking University Third Hospital | 2020-10-10 |
| Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate (NCT04511702) | Amgen | 2020-10-02 |
| Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information (NCT04853160) | Takeda | 2020-08-15 |
| Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects (NCT04303039) | Atom Therapeutics Co., Ltd | 2020-05-22 |
| A Pilot Study to Explore the Role of Gut Flora in Gout (NCT04224662) | ProgenaBiome | 2020-03-02 |
| Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS) (NCT04130204) | Dyve Biosciences, Inc. | 2020-02-12 |
| The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults (NCT04139824) | LG Chem | 2020-01-22 |
| Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout (NCT04125459) | Attune Health Research, Inc. | 2020-01-22 |
| A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia (NCT03934099) | LG Chem | 2019-12-02 |
| Renal PK Study of LC350189 (NCT04066712) | LG Chem | 2019-11-19 |
| The the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XNW3009 in Health Subject (NCT04040907) | Evopoint Biosciences Inc. | 2019-11-13 |
| The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults. (NCT03927677) | LG Chem | 2019-11-05 |
| A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers (NCT04047394) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2019-10-22 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 (NCT04060173) | Atom Therapeutics Co., Ltd | 2019-09-05 |
| A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout (NCT04052932) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-16 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | ProgenaBiome | 2019-07-11 |
| Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout (NCT03994731) | Amgen | 2019-06-13 |
| Gout Self-Monitoring Aiming to Reach Target (NCT03274063) | University of Edinburgh | 2019-04-05 |
| A Nurse Led Patient Management Programme to Improve Outcomes in Gout (NCT03345186) | University Hospital, Basel, Switzerland | 2019-04-01 |
| Pharmacokinetics and Pharmacodynamics of Anthocyanins (NCT03650140) | Rutgers, The State University of New Jersey | 2019-02-01 |
| Study of of URC102 to Assess the Efficacy and Safety in Gout Patients (NCT04804111) | JW Pharmaceutical | 2019-01-21 |
| Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients (NCT04040816) | Shanton Pharma Co., Ltd. | 2019-01-01 |
| Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial (NCT04199325) | The Affiliated Hospital of Inner Mongolia Medical University | 2018-11-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects (NCT03906006) | Atom Therapeutics Co., Ltd | 2018-10-17 |
| Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout (NCT03635957) | Amgen | 2018-09-26 |
| The Diet Gout Trial (NCT03569020) | Johns Hopkins University | 2018-08-07 |
| The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients (NCT03601260) | Hillel Yaffe Medical Center | 2018-08-01 |
| Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis (NCT03416543) | University Hospital, Tours | 2017-12-13 |
| Evidence-based Laboratory Test Order Sets in Primary Care (NCT02950142) | Universitaire Ziekenhuizen KU Leuven | 2017-12-01 |
| The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout (NCT03306758) | Shanghai Zhongshan Hospital | 2017-11-01 |
| The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) (NCT03336203) | Medical Practice Prof D. Ivanov | 2017-10-30 |
| A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects. (NCT03388515) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2017-10-09 |
| D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers (NCT03291782) | InventisBio Co., Ltd | 2017-09-13 |
| Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence. (NCT03272425) | Ardea Biosciences, Inc. | 2017-08-14 |
| Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit (NCT03162341) | Lille Catholic University | 2017-08-10 |
| A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment (NCT03226899) | Ironwood Pharmaceuticals, Inc. | 2017-07-19 |
| Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level (NCT03211403) | Atridia Pty Ltd. | 2017-07-04 |
| CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat (NCT02579096) | VA Office of Research and Development | 2017-03-06 |
| The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout (NCT03131583) | Jiangsu HengRui Medicine Co., Ltd. | 2017-02-17 |
| Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions (NCT02903446) | University of Alabama at Birmingham | 2017-02-01 |
| Descriptive Analysis of Dual-energy Computed Tomography Exams of Adult Patients With Gout (NCT05065606) | Assistance Publique - Hôpitaux de Paris | 2016-11-30 |
| A Single Dose Study of SHR4640 in Healthy Male Volunteers (NCT03015948) | Atridia Pty Ltd. | 2016-09-22 |
| Novel Methods for Ascertainment of Gout Flares -A Pilot Study (NCT02855437) | University of Alabama at Birmingham | 2016-09-01 |
| Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration (NCT03038386) | Meander Medical Center | 2016-04-01 |
| Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study (NCT02578394) | Mid and South Essex NHS Foundation Trust | 2016-04-01 |
| Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels (NCT02648269) | Selecta Biosciences, Inc. | 2015-12-01 |
| Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (NCT02598596) | Ampel BioSolutions, LLC | 2015-12-01 |
| RDEA3170 PK/PD Study (NCT02608710) | Ardea Biosciences, Inc. | 2015-11-01 |
| Study of URC102 to Assess the Safety and Efficacy in Gout Patients (NCT02557126) | JW Pharmaceutical | 2015-10-01 |
| Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases (NCT02702375) | University of Toronto | 2015-09-01 |
| Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout (NCT02500641) | Menarini International Operations Luxembourg SA | 2015-08-17 |
| Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects (NCT02498652) | Ardea Biosciences, Inc. | 2015-07-28 |
| Prospective Analgesic Compound Efficacy (PACE) Study (NCT02403687) | Express Specialty Pharmacy | 2015-06-01 |
| Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors (NCT02716870) | University of Toronto | 2015-06-01 |
| Optimal Administration of Allopurinol in Dialysis Patients (NCT02477488) | Maisonneuve-Rosemont Hospital | 2015-06-01 |
| Pharmacogenetics of SGLT2 Inhibitors (NCT02462421) | University of Maryland, Baltimore | 2015-06-01 |
| Elastography as Gouty Arthropathy Outcome (EGO) (NCT02471261) | Arthritis & Rheumatism Associates, P.C. | 2015-05-01 |
| Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels (NCT02464605) | Selecta Biosciences, Inc. | 2015-05-01 |
| Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases (NCT03214263) | Rigshospitalet, Denmark | 2015-05-01 |
| Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout (NCT02330796) | Revive Therapeutics, Ltd. | 2015-04-01 |
| DECT Study in Allopurinol-Treated Gout Patients (NCT02393560) | Ardea Biosciences, Inc. | 2015-04-01 |
| Food Effect Study of Febuxostat XR in Healthy Participants (NCT02374164) | Takeda | 2015-02-01 |
| A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout (NCT02287818) | TWi Biotechnology, Inc. | 2014-12-01 |
| RDEA3170 Bioavailability Study (NCT02336594) | Ardea Biosciences, Inc. | 2014-11-01 |
| RDEA3170 and Febuxostat Combination Study in Gout Subjects (NCT02246673) | Ardea Biosciences, Inc. | 2014-10-01 |
| Mild, Moderate and Severe Renal Impairment Study (NCT02219516) | Ardea Biosciences, Inc. | 2014-08-01 |
| Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout (NCT02252835) | Gilead Sciences | 2014-08-01 |
| Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients (NCT02290210) | JW Pharmaceutical | 2014-07-24 |